Actively Recruiting
Evaluating Serplulimab with Induction Chemotherapy and Radiotherapy Compared to Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma
Led by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Updated on 2026-09-17
710
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and effectiveness of combining induction chemotherapy with serplulimab, followed by maintenance therapy, in patients with locally advanced nasopharyngeal carcinoma LA-NPC. This phase III trial compares this approach with the standard cisplatin-based concurrent chemoradiotherapy CCRT combined with serplulimab maintenance. The study focuses on patients who respond well to initial treatment and aims to determine if omitting concurrent chemotherapy impacts outcomes. Participants first receive induction chemotherapy consisting of gemcitabine and cisplatin combined with serplulimab for three cycles. Those who achieve significant tumor shrinkage and undetectable plasma EBV DNA are then randomly assigned to either receive radiotherapy alone followed by serplulimab maintenance or to receive cisplatin-based concurrent chemoradiotherapy followed by serplulimab maintenance. Radiotherapy is delivered using intensity-modulated techniques with specific dosing schedules. Serplulimab is given during induction and for 14 maintenance cycles. During the study, participants undergo regular assessments including tumor imaging, plasma EBV DNA testing, and evaluations of hearing loss and quality of life using validated questionnaires. Researchers monitor event-free survival, overall survival, distant metastasis-free survival, and locoregional recurrence-free survival over several years. Adverse events are tracked through both investigator and patient reports. The total study duration extends up to 5 years post-radiotherapy to assess long-term outcomes and safety.
CONDITIONS
Brief Title
Serplulimab Combined With Induction Chemotherapy and Radiotherapy in Nasopharyngeal Carcinoma
Research Team
C
Chao Wan
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here